Most people hit this wall between weeks 24 and 36
Knowing how to properly prepare and administer the semaglutide weekly injection helps build confidence
Weight loss can stall because your body adapts, your metabolism changes, your calorie needs decrease or another health factor is affecting your progress
The Key Takeaways: Most common: Nausea (43%), manageable with dietary changes and timing Unique: Dysesthesia (20.9%), mild tingling sensations, not seen with Wegovy/Mounjaro Timeline: Worst during dose escalation (weeks 116), significant improvement after Discontinuation: 18.2% in TRIUMPH-4, 11.3% in TRIUMPH-1 the general obesity population tolerates it better than the osteoarthritis cohort Reversible: Stopping medication reverses side effects For most people with obesity especially severe obesity the 28.328.7% weight loss and associated health benefits outweigh the temporary discomfort during the first few months
Suunnittelija antaa asiakkaalle ideoita ja neuvoja ongelman ratkaisuun
Pregnant individuals, those with severe renal or hepatic impairment, and patients with a history of pancreatitis require specific clinical evaluation